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A

lzheimer’s disease (AD) is a progressive brain disorder that gradually
destroys an individual’s mental functioning and social capabilities,
including the ability to carry out everyday activities. Although memory
deﬁcits affect AD patients’ ability to perform these activities, research
suggests that visual perception impairments also contribute. One impaired visual
perception ability, contrast sensitivity, enables one to distinguish an object from
its immediate surroundings. The present project measured contrast sensitivity in
a real-world task by having AD patients ﬁnd a pill of various shades of gray on a
tiled background. Results were compared to young and elderly control participants.
Participants also ﬁlled out a questionnaire examining activities of daily living
(ADLs). Results demonstrated that impairments in contrast sensitivity were
observed both as a function of normal aging and as a result of AD. Performance
correlated with the ADLs of household care and travel for both groups. Increasing
contrast in environmental settings may aid these individuals, especially AD
patients, in living a more independent lifestyle.
Research Question
How does the manipulation of contrast affect Alzheimer’s disease patients’
ability to detect a pill on a white-tiled surface? Do these ﬁndings relate to
problems in activities of daily living experienced by these patients?

Clinical Neuropsychology.

Introduction
General Introduction. Alzheimer’s disease (AD) is a progressive brain disorder
that gradually destroys an individual’s mental functioning and social
capabilities, including memory, reasoning, decision-making, communication,
and the ability to carry out everyday activities. According to the Alzheimer’s
Association, AD affects approximately 4.5 million Americans annually. By
the year 2050, this number is expected to increase to 11.3 to 16 million.
Although memory deﬁcits are a primary symptom of AD and the one most
often researched, other abilities including those in visual perception are also
impaired (Cronin-Golomb, A., 1995; Gilmore, G. C., Cronin-Golomb, A.,
Neargarder, S., & Morrison, S. R. 2005; Mendola, J. D., Cronin-Golomb,
A., Corkin, S. & Growdon, J. H., 1995; Neargarder, S. 2005). One impaired
ability known as contrast sensitivity has direct implications for the ability of
AD patients to carry out everyday activities. Contrast sensitivity is deﬁned as
the smallest difference in intensity that a person can resolve between an object
and its immediate surroundings. For example, what shade of gray would an
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electrical outlet need to be before a patient could detect it against
a white wall? Research shows that deﬁcits in contrast sensitivity
directly affect everyday activities such as food and liquid intake
(Dunne, Neargarder, Cipolloni, & Cronin-Golomb, 2004)
object detection (Neargarder & Cronin-Golomb, 2005),
and face discrimination (Cronin-Golomb, Cronin Golomb,
Dunne, Brown, & Jain, 2000).
Background. A number of research studies have identiﬁed
contrast sensitivity impairments in AD patients (Cronin
Golomb, Growden, & Corkin, 1995; Cronin-Golomb,
Gilmore, Neargarder, Morrison, & Laudate, 2007). Results
from these studies were obtained in a laboratory setting using
a series of clinical vision charts such as the Vistech and the
FACT (Functional Acuity Contrast Test). These tests allow
one to measure contrast deﬁcits across a range of different
spatial frequencies. Results show that AD patients exhibit
contrast deﬁcits across all levels of spatial frequency. This
would potentially make it difﬁcult for patients to distinguish
between people, places, and things in a real-world environment.
Although research has demonstrated that deﬁcits measured in
a laboratory setting using vision charts relate to deﬁcits in the
real-world, we have no direct measure of contrast sensitivity
in real-world tasks. For example, although we may know that
patients will do better in a high-contrast task (pouring milk
into a black mug) than a low-contrast task (pouring milk into
a white mug), we do not know what the contrast between the
two items (milk and cup) needs to be in order for the patient
to succeed at this task.
Present Project. The present project aimed to measure contrast
sensitivity in a real-world task by having AD patients ﬁnd pills
of various shades of gray on a tiled background (simulating a
white-tiled ﬂoor). This method allowed us to ﬁnd the exact
contrast the pill needs to be to the background in order for
patients to be able to successfully ﬁnd the pill. These ﬁndings
were then compared to a questionnaire that measured general
activities of daily living. This enabled us to compare laboratory
based tests to everyday functioning. The results from this study
aim to increase the functional independence of AD patients,
both in the home environment and nursing home facilities.
This increase in independence can result in reducing health
care costs and increase the overall well-being of patients.
Methodology
Participants. This study consisted of 15 patients with
AD, 13 healthy elderly control participants (EC) and 25
young participants (YC). EC participants were community
volunteers and AD patients were recruited from Community
Family Incorporated (AD day programs) located in Lowell
and Medford, Massachusetts. Participants were matched on
education, age, and near acuity.
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Materials and Procedures. Materials consisted of a questionnaire
that measured activities of daily living, and four conditions that
measured the ability of participants to identify a pill of varying
contrast levels on a tiled surface. Each measure is described in
detail below.
Questionnaire. The Activities of Daily Living Scale (ADL) was
given to each participant and his/her caregiver or informant.
The ADL scale consists of 28 items that cover areas of self-care,
household care, employment/recreation, shopping/money, and
travel/communication.
Pill Study. The pill study consisted of four different conditions.
Two of these conditions were naturalistic and two were
computerized. When conducting research with patient
populations it is often the case that researchers use computerized
stimuli to measure abilities and then generalize these ﬁndings
to the real-world. It is unclear, however, whether one can make
direct statements about real-world abilities based on these
artiﬁcial measurements. One goal of this study was to compare
performance on computerized assessments to performance on
comparable naturalistic assessments. As such, two naturalistic
conditions were developed. The ﬁrst used a real pill on a real
background (N1: completely naturalistic), while the second used
a printed pill on a real background (N2: partially naturalistic).
The contrast of the pill to the background was identical in
both conditions. The ﬁrst computerized condition (C1) was
perceptually identical to condition N2 (contrast values are
identical, luminance values are different), except it was presented
on a computer, whereas the second computerized condition
(C2) was physically similar to condition N2 (both contrast and
luminance values were similar) but was perceptually different
than N2. The rationale for including these four conditions was
to aid in differentiating the factors that contribute to the ability
of an Alzheimer’s patient to detect an object of varying shades
of contrast on an identiﬁed surface and to determine whether
performance differed between computerized and naturalistic
assessments. Each of the four conditions used seven pills of
varying shades measured using a Minolta CS-100 photometer.
Shade one was the lightest and the hardest to see and shade
seven was the darkest and the easiest to see. The luminance
of each of the seven pills was measured against the luminance
of the tiled background to result in seven different contrast
levels per condition. For all conditions, the contrast of the pill
relative to the background ranged from 1.2% to 6.6%.
Naturalistic Version 1(real pill: N1). In this version, pills were
created to emulate a 10 mg donepezil HCL tablet. This drug
is commonly prescribed to individuals with AD. Pills were
presented on an 8.5’’ x 11” piece of paper printed with a six
by six grid comprised of 36 squares meant to represent a tiled
BRIDGEWATER STATE COLLEGE

background. Each of the seven pills was presented randomly
four times per quadrant for a total of 112 trials. A white
screen was used to conceal the placement of the pill from the
participant before each trial. Participants were instructed to
locate and touch the pill as quickly as possible. Reaction times
were recorded.
Naturalistic Version 2 (printed pill: N2). In this version, pills
were printed onto a tiled background; real pills were not used.
The background from N1 remained the same. A photometer
was used to verify the contrast values. Trials were bound using
3 binders and were presented to participants by ﬂipping the
pages like a book. Like in N1, 112 trials were presented and
reaction times were recorded.
Computerized Version 1 (high luminance: C1).Using Adobe
Photoshop, trials perceptually similar to both N1 and N2
were created. The same counterbalancing and randomization
from conditions N1 and N2 were used and presented on a
calibrated touch screen monitor using Superlab 4.0. This
program recorded the area touched by the participant and
reaction times.
Computerized Version 2 (low luminance: C2). A different
computerized version was created with the luminance and
contrast values similar to the naturalistic versions. Again
contrast values of the pills were consistent with those used in
C1. Randomization, counterbalancing and presentation were
also consistent with C1. Reaction time was measured using
Superlab 4.0.
Results
Reaction time data were analyzed by using mixed design
analyses of variance followed by a priori comparisons using
an adjusted alpha level for each condition. Correlational
analyses were also performed between the pill reaction time
data and the ADL scale. Any and all violations regarding the
use of parametric statistics were properly addressed. For ease of
presentation, results are displayed graphically using symbols to
indicate signiﬁcant differences between groups. Results of all of
the individual analyses are not listed.
Naturalistic Version 1(real pill: N1). For normal aging (YCs
versus ECs), there were no signiﬁcant differences in reaction
time across the seven contrast levels. However, AD patients
differed from EC participants at all contrast levels (see Figure
1).
Naturalistic Version 2 (printed pill: N2). For normal aging
(YCs versus ECs), there were signiﬁcant differences in slower
latency times in contrast levels two through six. However, AD
BRIDGEWATER STATE COLLEGE

participants compared to ECs showed signiﬁcant differences
for levels two through ﬁve, no differences were noted at levels
six or seven (see Figure 2).
Computerized Version 1 (high luminance: C1). For normal aging
(YCs versus ECs), there were signiﬁcant differences in reaction
time across contrast levels two through seven. AD participants
when compared to ECs did not show signiﬁcant differences
across any of the seven contrast levels (see Figure 3).
Computerized Version 2 (low luminance: C2). For normal aging
(YCs versus ECs), there were differences in reaction time across
contrast levels three through seven. When AD patients were
compared to ECs there were differences across contrast levels
three through seven. (see Figure 4).
Everyday Functioning Questionnaire. For both AD and EC
groups, signiﬁcant positive correlations were noted between
RT performance and the ADLs of household care and travel.
Discussion
In regards to normal aging, results indicated that EC performance when compared to YC performance was signiﬁcantly
slower for the printed pill (N2), computerized high (C1), and
computerized low (C2) conditions. Most likely, the additive effect of decreased contrast across conditions and low-luminance
stimuli resulted in poorer performance; the EC had more difﬁculty seeing the pills. Both YC and EC performance was
similar on the Real Pill (N1) condition; this suggests that the
cue of depth and the naturalism of the stimuli enhanced the
detection of the object despite low luminance. An implication
of the Naturalistic 3-D Pill appears to be that for a nearby and
a non-cultured real world assessment, depth is a strong indicator of performance and that in some cases, if depth is present,
contrast deﬁcits may be minimized. These ﬁndings were also
related to the ADLs of household care and travel. Taken together, these results support the ﬁndings that EC individuals
demonstrate impairments in contrast sensitivity and that these
impairments directly relate to real-world functioning.
When compared to the EC group, individuals with AD
exhibited slower latency times on all pill conditions except for
the Computer High-Luminance condition (C1). The lack of a
signiﬁcant difference between EC and AD individuals for this
condition was most likely due to the added beneﬁt of increased
luminance provided by the computer monitor. Though they
did not make any errors on the Naturalistic 3-Dimensional
Pill (N1), they were slower than the EC group at all contrast
levels. Differences in performance were also observed for the
Computer Low-Luminance Condition (C2). In general, the
AD group exhibited slower reaction times than the EC group
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across contrast levels most likely due to the low luminance and
contrast levels of the stimuli.
An interesting pattern emerged for the Naturalistic PrintedPill condition (N2). Here, differences between the AD and
EC participants were observed at the lower contrast levels but
not the higher ones (contrast levels 6 and 7). At these levels,
the AD and EC participants exhibited similar reaction times.
These results suggest that in certain conditions, if the contrast
of the stimuli is high enough, performance differences between
groups disappear. Overall, ﬁndings suggest that by increasing
the luminance and contrast of stimuli, one can potentially
compensate for contrast sensitivity losses noted in the AD
population. Similarly to the EC group, ﬁndings were related to
the ADLs of household care and travel thereby suggesting that
losses in contrast sensitivity relate to everyday functioning.
These results suggest that individuals with AD exhibit
contrast deﬁcits beyond those that occur with normal aging.
These deﬁcits most likely impair their ability to function
independently. In addition, results tend to differ depending
on a variety of factors including the overall luminance of
the stimuli used, the contrast of the stimuli when compared
to a background, and whether the stimuli are presented in a
naturalistic or computerized form. All of these things should be
taken into account when generalizing laboratory results to realworld conditions. Finally, by examining the results of the four
conditions, one can pinpoint where performance falls off for AD
patients. This information can be used to create environments
that help to minimize the visual deﬁcits experienced by these
patients.
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Interventions to improve visual function, speciﬁcally contrast
enhancement and increased luminance, may be of practical
use in improving the everyday functioning of older adults.
For example, it may be of use for individuals when managing
their medications. If the right level of contrast is used in the
environment wherein individuals with AD reside, they will
be better able to detect pills on a surface which will increase
medication adherence. Increasing contrast in environmental
settings can aid AD patients in living a more independent
lifestyle.
Acknowledgements
I would like to thank the Adrian Tinsley Program and The
Ofﬁce of Undergraduate Research for funding and supporting
my summer project. I would also like to thank the Boston
University Vision and Cognition Laboratory and my mentor
Dr. Sandra Neargarder for their support and encouragement.
This research was supported by a grant obtained through
Boston University- RO1 NS052914 and through an ATP
Summer Grant funded by Bridgewater State College.
Figures
For each of the ﬁgures that follow, reaction time (in log units)
is plotted as a function of Michleson contrast values (also in
log units). Each of the seven data points represent the mean
reaction time for that contrast level. From left to right, the
contrast levels are given in order ranging from contrast level 1
(the most difﬁcult to see) to contrast level 7 (the easiest to see).
Vertical bars represent the standard error of the mean for each
condition. Results are plotted for the YC, EC, and AD groups.
The symbol ‘†’ represents a signiﬁcant difference between the
YC and EC groups and the symbol ‘*’ represents a signiﬁcant
differnce between the EC and AD groups.
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Figure 1. Naturalistic 3-Dimensional Pill

Figure 3. Computer Version 1 ( High Luminance)

Figure 2. Naturalistic Version 2 (Printed Pill)

Figure 4. Computer Version 2 ( Low Luminance)
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